NIPC Law

Author   Hellerhoff   Licence  CC BY-SA 3,0 Jane Lambert Patents Court (Mr Justice Birss ) Evalve Inc and others v Edwards Lifesciences Lt d [2020] EWHC 1524 (Pat) (18 June 2020) In    Evalve Inc and others v Edwards Lifesciences Ltd #1 [ 2020] EWHC 514 (Pat) (12 March 2020)). Mr Justce Birss held that two patents that protected the market for a device known as the MitraClip were valid and infringed.   In  E valve Inc and others v Edwards Lifesciences Ltd (#2) [2020] EWHC 513 (Pat) (12 March 2020) Mr Justice Birss rejected the defendant's contention that it should be allowed to market its product notwithstanding the judgment on the ground that some patients were assisted by a product that competed with the MitraClip but not by the MitraClip itself. I blogged about those cases in   Patents - Evalve Inc. and Others v Edwards Lifesciences Ltd. #1   27 March 2020 NIPC Law and Patents - Evalve Inc. and Others v Edwa...

Skeletal Formula of Daptomycin Author  Fvasconcellos Licence copyright waived by the author Wikipedia Jane Lambert Court of Appeal (Lord Justices Lewison and Kitchin)  Hospira UK Ltd v Cubist Pharmaceuticals LLC [2018] EWCA Civ 12 (18 Jan  2018) Daptomycin is an antibiotic used to treat systemic and life-threatening infections caused by multiple drug resistant bacteria. Its effectiveness depends on its purity. The invention for which the patent in suit was  granted was a way of purifying the antibiotic. In Hospira UK Ltd v Cubist Pharmaceuticals LLC [2016] EWHC 1285 (Pat) (10 June 2016),  Hospira UK Ltd , (a British subsidiary of Pfizer) sought the revocation of that patent.  Mr Justice Henry Carr found that the patent was invalid and ordered its revocation. Cubist Pharmaceuticals LLC  (a subsidiary of Merck & Co.) appealed against that judgment and order in Hospira UK Ltd v Cub...